Johnson & Johnson wins EU approval for new gMG treatment
Nipocalimab authorised for adults with antibody-positive generalised myasthenia gravis
Read More
Author: John Pinching
Pharvaris reports positive phase 3 results for HAE treatment
Deucrictibant shows rapid symptom relief and strong safety profile in RAPIDe-3 study
Read More
AlzeCure secures EU grant for Alzheimer’s drug trial
Funding supports phase 2 study of NeuroRestore ACD856 in patients
Read More
The young ones
Pharma’s new leaders – attracting and empowering young talent
Read More
Vandria reports positive phase 1 data for Alzheimer’s drug candidate
Company highlights safety and target engagement results for VNA-318 at CTAD meeting
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
